<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: oops FW: MED/BIO: Get a Cold, Kill Cancer</title>
<meta name="Author" content="Emlyn O'regan (oregan.emlyn@healthsolve.com.au)">
<meta name="Subject" content="oops FW: MED/BIO: Get a Cold, Kill Cancer">
<meta name="Date" content="2003-05-08">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>oops FW: MED/BIO: Get a Cold, Kill Cancer</h1>
<!-- received="Thu May  8 21:01:31 2003" -->
<!-- isoreceived="20030509030131" -->
<!-- sent="Fri, 9 May 2003 12:31:08 +0930" -->
<!-- isosent="20030509030108" -->
<!-- name="Emlyn O'regan" -->
<!-- email="oregan.emlyn@healthsolve.com.au" -->
<!-- subject="oops FW: MED/BIO: Get a Cold, Kill Cancer" -->
<!-- id="7A2B25F8EB070940996FA543A70A217BBFDC7D@adlexsv02.protech.com.au" -->
<!-- charset="iso-8859-1" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Emlyn O'regan (<a href="mailto:oregan.emlyn@healthsolve.com.au?Subject=Re:%20oops%20FW:%20MED/BIO:%20Get%20a%20Cold,%20Kill%20Cancer"><em>oregan.emlyn@healthsolve.com.au</em></a>)<br>
<strong>Date:</strong> Thu May 08 2003 - 21:01:08 MDT
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="7897.html">Terry W. Colvin: "FWD [fort] Global GIGO"</a>
<ul>
<li><strong>Previous message:</strong> <a href="7895.html">Emlyn O'regan: "RE: MED/BIO: Get a Cold, Kill Cancer"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#7896">[ date ]</a>
<a href="index.html#7896">[ thread ]</a>
<a href="subject.html#7896">[ subject ]</a>
<a href="author.html#7896">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Obviously that wasn't meant for the list. If you read it, please poke out
<br>
your eyes!
<br>
<p>(my credit card number isn't in there somewhere, is it?)
<br>
<p>Emlyn
<br>
<p><em>&gt; -----Original Message-----
</em><br>
<em>&gt; From: Emlyn O'regan 
</em><br>
<em>&gt; Sent: Friday, 9 May 2003 12:29 PM
</em><br>
<em>&gt; To: '<a href="mailto:extropians@extropy.org?Subject=Re:%20oops%20FW:%20MED/BIO:%20Get%20a%20Cold,%20Kill%20Cancer">extropians@extropy.org</a>'
</em><br>
<em>&gt; Subject: RE: MED/BIO: Get a Cold, Kill Cancer
</em><br>
<em>&gt; 
</em><br>
<em>&gt; 
</em><br>
<em>&gt; As far as I remember, the source is:
</em><br>
<em>&gt; &lt;rest of stupid stuffup snipped&gt;
</em><br>
<em>&gt; 
</em><br>
<em>&gt; &gt; -----Original Message-----
</em><br>
<em>&gt; &gt; From: Greg Burch [mailto:<a href="mailto:gregburch@gregburch.net?Subject=Re:%20oops%20FW:%20MED/BIO:%20Get%20a%20Cold,%20Kill%20Cancer">gregburch@gregburch.net</a>]
</em><br>
<em>&gt; &gt; Sent: Friday, 9 May 2003 10:34 AM
</em><br>
<em>&gt; &gt; To: <a href="mailto:extropians@extropy.org?Subject=Re:%20oops%20FW:%20MED/BIO:%20Get%20a%20Cold,%20Kill%20Cancer">extropians@extropy.org</a>
</em><br>
<em>&gt; &gt; Subject: MED/BIO: Get a Cold, Kill Cancer
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; This seems Really Important -- is it?
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; <a href="http://www.chron.com/cs/CDA/ssistory.mpl/metropolitan/1899204">http://www.chron.com/cs/CDA/ssistory.mpl/metropolitan/1899204</a>
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; May 7, 2003, 9:36AM
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; Cold virus outsmarts, destroys brain tumors
</em><br>
<em>&gt; &gt; Genetically engineered cells target only cancers
</em><br>
<em>&gt; &gt; M.D. Anderson plans clinical trials for next year
</em><br>
<em>&gt; &gt; By TODD ACKERMAN
</em><br>
<em>&gt; &gt; Copyright 2003 Houston Chronicle Medical Writer
</em><br>
<em>&gt; &gt; RESOURCES 
</em><br>
<em>&gt; &gt; . Graphic: Virus kills brain tumors
</em><br>
<em>&gt; &gt;  
</em><br>
<em>&gt; &gt; Local scientists have turned a cold virus into a kind of 
</em><br>
<em>&gt; &quot;smart bomb&quot;
</em><br>
<em>&gt; &gt; that may be able to destroy the deadliest form of brain cancer. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; In experiments with mice, University of Texas M.D. Anderson Cancer
</em><br>
<em>&gt; &gt; Center researchers are reporting that a genetically 
</em><br>
<em>&gt; engineered version
</em><br>
<em>&gt; &gt; of the common cold infected and killed malignant glioma cells that
</em><br>
<em>&gt; &gt; resist other therapy. The virus doesn't harm normal tissue. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; &quot;Viral therapy like this may be just what we need to treat a complex
</em><br>
<em>&gt; &gt; disease like cancer,&quot; said Dr. Frederick Lang, a professor of
</em><br>
<em>&gt; &gt; neurosurgery and primary investigator of the study. &quot;Cancer can be
</em><br>
<em>&gt; &gt; devious the way it does everything possible to avoid 
</em><br>
<em>&gt; destruction, but
</em><br>
<em>&gt; &gt; viruses are equally tricky and may be able to outsmart 
</em><br>
<em>&gt; brain tumors.&quot; 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; In today's issue of the Journal of the National Cancer 
</em><br>
<em>&gt; Institute, M.D.
</em><br>
<em>&gt; &gt; Anderson researchers said the therapy produced a response on 
</em><br>
<em>&gt; &gt; glioma not
</em><br>
<em>&gt; &gt; previously seen with any other treatment. Clinical trials 
</em><br>
<em>&gt; with people
</em><br>
<em>&gt; &gt; are expected to begin late next year. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; Roughly 17,000 new cases of brain tumors are diagnosed in the United
</em><br>
<em>&gt; &gt; States every year and half are gliomas, a primary type which 
</em><br>
<em>&gt; &gt; arises from
</em><br>
<em>&gt; &gt; the brain itself rather than metastasizing from another location.
</em><br>
<em>&gt; &gt; Surgery, radiation therapy, steroids and chemotherapy can prolong
</em><br>
<em>&gt; &gt; survival, but most everyone dies within a year. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The virus is designed in such a way that to reproduce itself, it can
</em><br>
<em>&gt; &gt; only replicate in cancer cells, not healthy tissue. While 
</em><br>
<em>&gt; reproducing,
</em><br>
<em>&gt; &gt; it kills cancer cells, and when no more are left to infect, 
</em><br>
<em>&gt; the virus
</em><br>
<em>&gt; &gt; simply dies. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The idea of using viruses to kill cancer cells has been 
</em><br>
<em>&gt; &gt; around since the
</em><br>
<em>&gt; &gt; 1950s, but it is only in recent years that it is moving toward
</em><br>
<em>&gt; &gt; application. Therapeutic viruses for lung cancer and head and neck
</em><br>
<em>&gt; &gt; cancer are in clinical trials, said Howard Fine, director 
</em><br>
<em>&gt; of the brain
</em><br>
<em>&gt; &gt; tumor program at the National Cancer Institute. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The NCI is providing $1 million to produce the drug-grade 
</em><br>
<em>&gt; &gt; version of the
</em><br>
<em>&gt; &gt; therapy in its laboratories. It is scheduled to be finished 
</em><br>
<em>&gt; in time to
</em><br>
<em>&gt; &gt; start enrolling patients in a study in the winter of 2004. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; But Fine warned against expecting too much from the 
</em><br>
<em>&gt; therapy. He called
</em><br>
<em>&gt; &gt; it &quot;a promising approach that is one of many good ideas out 
</em><br>
<em>&gt; &gt; there,&quot; but
</em><br>
<em>&gt; &gt; said success in animal models is a long way from success in human
</em><br>
<em>&gt; &gt; patients. He said it is unclear whether the virus will 
</em><br>
<em>&gt; &gt; replicate as well
</em><br>
<em>&gt; &gt; in humans, where glioma cells are surrounded by normal 
</em><br>
<em>&gt; cells; in mice,
</em><br>
<em>&gt; &gt; glioma cells cluster together. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; But the results in the mice were extraordinary. The virus cured 60
</em><br>
<em>&gt; &gt; percent of the glioma tumors implanted in mice brains whereas 
</em><br>
<em>&gt; &gt; mice given
</em><br>
<em>&gt; &gt; a placebo died after less than three weeks. (A precursor of 
</em><br>
<em>&gt; the virus
</em><br>
<em>&gt; &gt; cured 15 percent of the tumors.) 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The mice that survived treatment with the experimental virus 
</em><br>
<em>&gt; &gt; were killed
</em><br>
<em>&gt; &gt; for examination. Researchers found only empty cavities and 
</em><br>
<em>&gt; scar tissue
</em><br>
<em>&gt; &gt; where the tumors once were. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; &quot;This therapy needs more study, but it has a lot of 
</em><br>
<em>&gt; &gt; potential,&quot; said Dr.
</em><br>
<em>&gt; &gt; Juan Fueyo, a professor in M.D. Anderson's department of 
</em><br>
<em>&gt; &gt; neuro-oncology,
</em><br>
<em>&gt; &gt; the study's lead author and the developer of the genetically 
</em><br>
<em>&gt; &gt; engineered
</em><br>
<em>&gt; &gt; adenovirus. &quot;We've never had this kind of result with any kind of
</em><br>
<em>&gt; &gt; treatment on glioma -- in humans or animals.&quot; 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The virus is injected directly into the brain tumor 
</em><br>
<em>&gt; &gt; surgically, through
</em><br>
<em>&gt; &gt; a small hole. Lang expressed hope the therapy might work even 
</em><br>
<em>&gt; &gt; better in
</em><br>
<em>&gt; &gt; humans because delivery would be more precise. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; Researchers are studying human adenoviruses for a wide range 
</em><br>
<em>&gt; &gt; of medical
</em><br>
<em>&gt; &gt; uses, from cancer therapy to gene therapy, because they are 
</em><br>
<em>&gt; so good at
</em><br>
<em>&gt; &gt; infecting human cells. One question is how the immune system will
</em><br>
<em>&gt; &gt; respond -- will it overreact and cause illness or kill the virus, or
</em><br>
<em>&gt; &gt; will it be boosted to kill the cancer or other pathogen. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; But Lang said he's optimistic the treatment will accomplish its goal
</em><br>
<em>&gt; &gt; before the immune system goes after it. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; The research team also included scientists from the University of
</em><br>
<em>&gt; &gt; Alabama at Birmingham and the Institut Catala d'Oncologia in 
</em><br>
<em>&gt; &gt; Barcelona,
</em><br>
<em>&gt; &gt; Spain. 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; &gt; 
</em><br>
<em>&gt; 
</em><br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="7897.html">Terry W. Colvin: "FWD [fort] Global GIGO"</a>
<li><strong>Previous message:</strong> <a href="7895.html">Emlyn O'regan: "RE: MED/BIO: Get a Cold, Kill Cancer"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#7896">[ date ]</a>
<a href="index.html#7896">[ thread ]</a>
<a href="subject.html#7896">[ subject ]</a>
<a href="author.html#7896">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Thu May 08 2003 - 21:12:14 MDT
</em></small></p>
</body>
</html>
